林摄入量通过向PRODH/MAPK通路来抑制前列腺癌细胞中的放射性敏感性
Lei Chang1, Xinzhou Deng2, Shan Jiang2
1Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.
Radiation research
|October 30, 2025
概括
林代谢显著降低了前列腺癌 (PCa) 放射治疗的有效性. 用proline补充或增加proline脱酶 (PRODH) 损害了细胞和动物模型中的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 放射治疗是一种标准的前列腺癌 (PCa) 治疗方法,但其有效性可能受到瘤细胞代谢的影响.
- 了解影响放射敏感性的代谢途径对于改善PCa治疗结果至关重要.
研究的目的:
- 为了研究前列腺癌细胞对辐射反应中的proline代谢的作用.
- 为了确定调节proline代谢是否会影响PCa中的放射敏感性.
主要方法:
- 在LNCaP和C4-2细胞中使用殖民地形成和瘤球体测定来评估辐射敏感性.
- 评估了细胞入侵,氨酸脱酶 (PRODH) 表达和MAPK通过西式斑点信号传递.
- 使用外源性普罗林补充剂,PRODH敲除,以及体内异种移植模型进行验证.
主要成果:
- X射线照射抑制了PCa细胞的生长和入侵,但通过林补充剂减弱了这种作用.
- 辐射上调的PRODH和下调的酸化MAPK (p-MAPK).
- PRODH敲击取消了proline对辐射疗效的抑制作用,在体外和体内得到证实.
结论:
- 林代谢在调节前列腺癌辐射敏感性方面发挥着重要作用.
- 林补充剂和PRODH活性可能会降低PCa放射治疗的疗效.
- 向普罗林代谢可能是提高前列腺癌放射治疗结果的策略.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


